PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents

Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo

NCT04103060 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo

NCT04822584 ·Status: COMPLETED ·Phase: PHASE2

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

NCT07431177 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

NCT06113471 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

NCT05583526 ·Status: COMPLETED ·Phase: PHASE3

A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

NCT03099304 ·Status: COMPLETED ·Phase: PHASE2

A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo

NCT07251595 ·Status: RECRUITING ·Phase: PHASE2

Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo

NCT00134368 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

NCT06113445 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06212999 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

NCT06113328 ·Status: TERMINATED ·Phase: PHASE2

Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo

NCT04530344 ·Status: COMPLETED ·Phase: PHASE3

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

NCT06163326 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

NCT06801821 ·Status: RECRUITING

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT05620823 ·Status: COMPLETED ·Phase: PHASE3

Evaluation Safety ,Efficacy Baricitinib Plus Excimer Light Versus Excimer Light Alone in Non Segmental Vitiligo

NCT05950542 ·Status: UNKNOWN

A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo

NCT06118411 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

NCT07172347 ·Status: RECRUITING ·Phase: PHASE2

Open-label Pilot Study of Abatacept for the Treatment of Vitiligo

NCT02281058 ·Status: UNKNOWN ·Phase: PHASE1

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

NCT06840392 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

NCT06516952 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants

NCT03004768 ·Status: COMPLETED ·Phase: PHASE1

Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.

NCT00417820 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NCT06548360 ·Status: RECRUITING ·Phase: PHASE3

Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.

NCT03941808 ·Status: COMPLETED ·Phase: NA